Summary
- Main use
- Treatment of congenital hypo- or afibrinogenemia and acquired hypofibrinogenemia
- Who receives it
- Adults
- Adult administration
- Dissolve 3 g in one dose in Water for Injection and administer intravenously. Repeat according to symptoms until the plasma fibrinogen level reaches the desired level. Adjust the dose appropriately according to body weight, age, and symptoms.
Ingredients
- Manufacturer
- Green Cross Co., Ltd.
Efficacy & effects
Treatment of congenital hypo- or afibrinogenemia and acquired hypofibrinogenemia
- Congenital hypo- and afibrinogenemia
- acquired hypofibrinogenemia
View approved original textHide original text
This medication is used for congenital hypofibrinogenemia and acquired hypofibrinogenemia.
How it is given
Adult administration
Dissolve 3 g in one dose in Water for Injection and administer intravenously. Repeat according to symptoms until the plasma fibrinogen level reaches the desired level. Adjust the dose appropriately according to body weight, age, and symptoms.
Precautions
This medicine is made from human plasma and cannot completely eliminate the risk of infections from viruses and other infectious agents that can be transmitted through blood. It is particularly recommended for hemophilia patients or patients with severely weakened immune systems to receive appropriate vaccinations, such as the Hepatitis A vaccine, and that doctors regularly check for infections when using this medication. It is important to explain the infection risks to patients when using this medication and to use it minimally only when necessary for treatment. Individuals allergic to this medication or its components should not use it, and careful use is necessary for patients with hemolytic anemia or severe anemia, as well as those with impaired immune function. Allergic reactions such as chills or fever may occur when using this medication, and in severe cases, anaphylactic shock may happen, so symptoms should be closely monitored. Also, due to the risk of thrombosis, the condition should be monitored carefully through blood tests, etc. There have been reports of liver dysfunction or viral infections such as Non-A, Non-B hepatitis, so appropriate actions should be taken if any liver issues arise. This medication cannot completely eliminate viruses, so careful monitoring of the patient's condition after administration is necessary due to infection possibilities. It is necessary to explain the infection risks to the patient before treatment and obtain their understanding. Remember that this medication is for patients with a very low fibrinogen level by nature. The safety of this medication during pregnancy has not been established, and there is a possibility of Parvovirus B19 infection, which may pose risks to the fetus, so it should only be used in pregnant or potentially pregnant women when the benefits outweigh the risks. Elderly patients may have decreased bodily functions, so they should be observed closely and administered with caution. When administering, it is recommended to use a transfusion set with a micropore filter and to inject slowly, as a rapid injection may lead to side effects such as intravascular coagulation or cyanosis. Should not be used if sediment is present when dissolving, and should not be mixed with other medications. Care should be taken when used together with dextran preparations as sediment may form. In cases of fluid abnormalities, it is advisable to improve the condition first with fluid injections before usage. Use within 1 hour after dissolution, and it is safe not to use any remaining medication due to the risk of bacterial contamination.
Side effects
- Chills
- fever
- anaphylactic shock
- dyspnea
- wheezing
- chest discomfort
- hypotension
- weak pulse
- cyanosis
- thrombosis
Show 9 moreCollapse
- deep vein thrombosis
- mesenteric thrombosis
- pulmonary embolism
- non-A hepatitis
- non-B hepatitis
- liver dysfunction
- acute and severe anemia
- fever
- persistent anemia
Not everyone experiences these, and they can vary from person to person.
Storage
This medication should be stored in a sealed container to prevent air from entering, in a cool place at a temperature below 10 degrees Celsius to maintain its effectiveness and safety.
Appearance and packaging
Appearance
A white to light yellow powder in a colorless and transparent vial, which becomes nearly colorless and slightly turbid when dissolved with the diluent.
Package unit
1 set/box [1 lyophilized vial (1 gram) + 1 diluent vial (50 milliliters)]
Questions about this medicine
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.